Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Denton

Showing results (31-40 of 607) with videos related to

Pageof 61
Sort By:
Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Pulmonary Complications of Connective Tissue DiseaseAthol Wells, Christopher P Denton
The British Journal of Dermatology|November 2, 2021
The critical need for patient-reported outcome measures to assess the severity and impact of systemic sclerosisM Hughes, C P Denton
Clinical and Experimental Rheumatology|January 22, 2026
Reply to the comment on: Impact of early immuno-suppressive therapy on pulmonary arterial hypertension in systemic sclerosis: a single-centre real-world studyStefano Rodolfi, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|February 3, 2021
Combining Data Sets as Well as Therapies Shows Improved Outcome in Connective Tissue Disease-Associated Pulmonary HypertensionChristopher P Denton, Julia Spierings
Lancet (London, England)|April 18, 2017
Systemic sclerosisChristopher P Denton, Dinesh Khanna
The Lancet. Rheumatology|January 27, 2024
Rational repurposing of tocilizumab for treatment of lung fibrosis in systemic sclerosisChristopher P Denton, Dinesh Khanna
Bailliere'S Best Practice & Research. Clinical Rheumatology|July 6, 2000
Scleroderma and related disorders: therapeutic aspectsC P Denton, C M Black
Current Rheumatology Reports|December 21, 2000
Novel therapeutic strategies in sclerodermaC P Denton, C M Black
Best Practice & Research. Clinical Rheumatology|May 26, 2004
Scleroderma--clinical and pathological advancesChristopher P Denton, Carol M Black
Current Rheumatology Reports|May 16, 2007
Therapy of pulmonary arterial hypertension in systemic sclerosis: an updateChristopher P Denton, Svetlana I Nihtyanova
Pageof 61

Showing results (31-40 of 607) with videos related to

Sort By:
Pageof 61
Seminars in Respiratory and Critical Care Medicine|May 29, 2019
Pulmonary Complications of Connective Tissue DiseaseAthol Wells, Christopher P Denton
The British Journal of Dermatology|November 2, 2021
The critical need for patient-reported outcome measures to assess the severity and impact of systemic sclerosisM Hughes, C P Denton
Clinical and Experimental Rheumatology|January 22, 2026
Reply to the comment on: Impact of early immuno-suppressive therapy on pulmonary arterial hypertension in systemic sclerosis: a single-centre real-world studyStefano Rodolfi, Christopher P Denton
Arthritis & Rheumatology (Hoboken, N.J.)|February 3, 2021
Combining Data Sets as Well as Therapies Shows Improved Outcome in Connective Tissue Disease-Associated Pulmonary HypertensionChristopher P Denton, Julia Spierings
Lancet (London, England)|April 18, 2017
Systemic sclerosisChristopher P Denton, Dinesh Khanna
The Lancet. Rheumatology|January 27, 2024
Rational repurposing of tocilizumab for treatment of lung fibrosis in systemic sclerosisChristopher P Denton, Dinesh Khanna
Bailliere'S Best Practice & Research. Clinical Rheumatology|July 6, 2000
Scleroderma and related disorders: therapeutic aspectsC P Denton, C M Black
Current Rheumatology Reports|December 21, 2000
Novel therapeutic strategies in sclerodermaC P Denton, C M Black
Best Practice & Research. Clinical Rheumatology|May 26, 2004
Scleroderma--clinical and pathological advancesChristopher P Denton, Carol M Black
Current Rheumatology Reports|May 16, 2007
Therapy of pulmonary arterial hypertension in systemic sclerosis: an updateChristopher P Denton, Svetlana I Nihtyanova
Pageof 61